NOVAMINE 11.4% Drug Patent Profile
✉ Email this page to a colleague
When do Novamine 11.4% patents expire, and what generic alternatives are available?
Novamine 11.4% is a drug marketed by Hospira Inc and is included in one NDA.
The generic ingredient in NOVAMINE 11.4% is amino acids. There are three hundred and fifty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Novamine 11.4%
A generic version of NOVAMINE 11.4% was approved as amino acids by B BRAUN on April 13th, 2012.
Summary for NOVAMINE 11.4%
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NOVAMINE 11.4% at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for NOVAMINE 11.4%
US Patents and Regulatory Information for NOVAMINE 11.4%
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira Inc | NOVAMINE 11.4% | amino acids | INJECTABLE;INJECTION | 017957-003 | Aug 9, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |